Area of research
Economics and Econometrics · Oncology
Research interest
Research interests include Medicine, Capecitabine, Gallbladder cancer, Biliary tract cancer, Pancreatic cancer, and Gemcitabine.
Evaluating the impact of financial navigation on financial catastrophe and distress for cancer care in Nigeria: A randomized control trial—COST-FIN.
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
Strong tumour cytidine deaminase (CDA) staining predicts for improved survival associated with sequential nab-Paclitaxel (nabP) and gemcitabine (GEM) chemotherapy as first line treatment of patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC)